Dr Philippe Beuzeboc

Specialty

Oncologist, urology expert

Title

Head of department

Hospital

Hôpital Foch (Suresnes)

Latest articles

• Vaccine refusal in cancer patients at the French hospital: a normative re-analysis through a 'neopotterian theory of global bioethics'. (Aug 13, 2025)
• Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial. (May 19, 2025)
• Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients. (May 9, 2025)
• Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary. (Mar 1, 2025)
• Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer. (Oct 30, 2024)